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Abstract 
Recent studies have suggested a sexually dimorphic role of spinal glial cells in the 
maintenance of mechanical hypersensitivity in rodent models of chronic pain. We have used 
the collagen antibody-induced arthritis (CAIA) mouse model to examine differences between 
males and females in the context of spinal regulation of arthritis-induced pain. We have 
focused on the late phase of this model when joint inflammation has resolved but mechanical 
hypersensitivity persists. While the intensity of substance P, CGRP and galanin 
immunoreactivity in the spinal cord was not different from controls, the intensity of microglia 
(Iba-1) and astrocyte (GFAP) markers was elevated in both males and females. Intrathecal 
administration of the glial inhibitors minocycline and pentoxifylline reversed mechanical 
thresholds in male, but not female mice. We isolated resident microglia from the lumbar 
dorsal horns and observed a significantly lower number of microglial cells in females by flow 
cytometry analysis. However, while genome-wide RNA sequencing results pointed to several 
transcriptional differences between male and female microglia, no convincing differences 
were identified between control and CAIA groups.  
 
Taken together, these findings suggest that there are subtle sex differences in microglial 
expression profiles independent of arthritis. Our experiments failed to identify the underlying 
mRNA correlates of microglial actions in the late phase of the CAIA model. It is likely that 
transcriptional changes are either subtle and highly localised and therefore difficult to identify 
with bulk isolation techniques or that other factors, such as changes in protein expression or 
epigenetic modifications are at play.  
 
Keywords: chronic pain; arthritis; microglia; sex difference; spinal cord; minocycline; 
RNAseq 
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Introduction 
Rheumatoid arthritis (RA) is an autoimmune disease that causes joint swelling and synovitis 
leading to progressive cartilage and bone destruction [31]. Chronic pain is one of the most 
debilitating symptoms of this process [22,52] and has long been attributed to peripheral 
inflammation. However, subgroups of patients report pain in spite of good medical control 
[2,3]. Moreover, RA patients can develop a generalized increase in pain sensitivity at distant 
sites from the inflamed joint [20,27,41], suggesting an involvement of the CNS [32]. This 
notion is supported by studies reporting elevated cytokine levels in the CSF of patients and in 
animal models of RA [25,26,35]. 
 
Microglia and astrocytes have emerged as crucial players in the maintenance of mechanical 
hypersensitivity [1,6,14,17,35,56] which upon activation synthesize and release factors that 
facilitate neuronal excitability and transmission of nociception [45,55]. Moreover, intrathecal 
delivery of glial inhibitors, such as minocycline or pentoxifylline, can prevent or reverse 
mechanical hypersensitivity in pain models [15,23].  
 
While arthritis and autoimmunity research has been fairly balanced in the consideration of 
both sexes, the majority of preclinical pain research has been performed in male animals. This 
is problematic in the context of studying pain in arthritis, since RA, like other autoimmune 
diseases, is more likely to occur in women [24]. Furthermore, in an experimental setting, 
many authors [5,33] – with some exceptions [43,44] – have come to the conclusion that there 
are sexual dimorphisms in how nociception and potentially other sensory stimuli [21] are 
processed. Recently, an effort has been made to include female rodents when studying models 
of chronic pain. As it is usual when scientific explorations are at an early stage, the results as 
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well as their accompanying potential explanations have been mixed. A few laboratories have 
suggested that mechanical allodynia is reversed only in male but not female mice after 
intrathecal delivery of microglial inhibitors [48,50]. The mechanisms underlying this 
phenomenon are still under debate [29,48]. No clear sex differences have so far been reported 
in the context of pain in arthritis models [1,35]. 
 
Here, we used the collagen antibody-induced arthritis (CAIA) model to investigate sexual 
dimorphisms in spinal signal transmission. In male mice, we have previously shown that 
spinal neuropeptide expression remains unchanged upon CAIA induction. Instead, we 
obtained evidence for the contribution of microglia and astrocytes in arthritis-induced pain in 
male mice. For instance, we demonstrated changes in microglial activation during the late 
phase of the CAIA model, when mechanical hypersensitivity persists but joint inflammation 
has resolved [1,6]. Moreover, we showed that intrathecal injection of drugs that interfere with 
astrocytic activity (pentoxifylline or JNK inhibitors) were able to reverse CAIA-induced 
mechanical hypersensitivity in male mice [6]. In the current study, we set out to confirm these 
findings – this time in both male and female mice. In addition to behavioural and 
immunohistochemical analyses, we also carried out genome-wide RNA-sequencing (RNA-
seq) during the late phase of the CAIA model in order to further characterize the role of these 
cells in the context of arthritis-induced pain, and to identify targets that can be used for 
intervention. We hypothesized that microglia would play a similar role in females compared 
to males, given that it has been reported that this cell type is associated with pain-like 
behaviour in female rats subjected to collagen-induced arthritis [14]. Interestingly, our results 
point towards a more complicated picture.  
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Materials and Methods 
 
Animals: Experimental procedures were carried out under ethical approval by the Northern 
Stockholm Animal Research Committee. Adult male and female Balb/cAnNRj (Janvier 
Labs), CBA (Harlan) (12-18 weeks old) and C57BL/6JRj (Janvier Labs) mice were used and 
housed in groups (3-5 mice per cage) in a temperature and humidity controlled environment 
with a 12h light/dark cycle and access to food and water ad libitum. Whole spinal cord 
experiments were carried out at King’s College London on 10 week old naïve male and 
female C57BL/6J mice in accordance with United Kingdom Home Office Legislation 
(Scientific Procedures Act 1986).  
 
Collagen antibody-induced arthritis (CAIA): For induction of arthritis, mice were injected 
intravenously (1.25-1.5 mg) with an anti-collagen type-II cocktail containing 5 different 
monoclonal autoantibodies (Chondrex) at day 0 followed by an intraperitoneal injection of 
LPS (25 µg in 100 µl; serotype 0111:B4; Chondrex, or 35 µg in 100 µl; serotype 055:B5; 
Sigma) at day 5.  
 
Scoring of arthritis: Joint inflammation of the fore and hind paws was evaluated visually as 
previously described [6]. Briefly, 1 point was given for every inflamed toe or knuckle. Each 
paw, ankle or wrist was awarded 2.5 or 5 points if moderately or severely inflamed, 
respectively, resulting in a maximum arthritis score of 15 points per leg and 60 points per 
mouse. Animals that did not reach a minimum of 12 points in the hind paws at the peak of 
inflammation were excluded from the study.  
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Mechanical hypersensitivity: Before testing, mice were acclimatized for 30-40 min in 
individual Plexiglas compartments with a wire mesh bottom. Mechanical hypersensitivity was 
assessed by applying calibrated Von Frey filaments (Optihair) of incremental force (0,03-3,30 
g) to the plantar surface of the hind paw using the up-down method [10]. The 50% paw 
withdrawal threshold (force at which the animal reacts 50% of the time) was calculated in 
grams for both hind paws and averaged. Three baseline testing sessions were performed on 
separate days and the average calculated for each animal. Results are presented as the average 
50% withdrawal threshold for each group.   
 
Intrathecal injections: Female and male mice were injected intrathecally with minocycline 
(30 µg in 5 µl; M9511, Sigma), pentoxifylline (30 µg in 5 µl; P1784, Sigma) or saline (5 µl, 
vehicle control) under light isoflurane anaesthesia in the late phase (> 60 days after CAIA 
induction). 
 
Immunohistochemistry: At 15 and 54 days after anti-collagen type-II antibody cocktail or 
saline injection, male and female mice were deeply anaesthetized and transcardially perfused 
with saline (0.9% NaCl) followed by a fixative solution (4% paraformaldehyde with 0.2% 
picric acid in 0.16 M phosphate buffer). Lumbar spinal cords were dissected, post-fixed for 90 
min at 4°C and cryoprotected with 10% sucrose in 0.1M phosphate buffer for 48 hours at 4°C. 
Spinal cords were then embedded in OCT compound (Tissue-Tek) and cut at 20 µm with a 
cryostat (Microm). Tissue sections were incubated overnight with primary antibodies against 
calcitonin gene-related peptide (CGRP) (1:32000, [38]), substance P (SP) (1:4000, [13]), 
galanin (1:4000, [53]), glial fibrillary acidic protein (GFAP) (1:8000, Dako) and ionized 
calcium-binding adapter molecule 1 (IBA-1) (1:2000, Wako) at 4°C. Immunoreactivity was 
visualized with the TSA Plus kit (Perkin Elmer) as previously described [8]. Images were 
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captured with a LSM710 confocal laser-scanning microscope (Carl Zeiss) and the integrated 
signal intensity was measured after background subtraction in 3 sections per animal using 
Image J (NIH). Results are shown as the percentage change in signal intensity in CAIA 
compared to the saline group.  
 
Microglial isolation: Male and female mice (naïve, saline injected or subjected to CAIA) 
were sacrificed by anesthetic overdose and transcardially perfused with ice-cold Hank’s 
Balanced Salt Solution (HBSS). Spinal cords were flushed out using a HBSS filled-syringe 
inserted in the tail end of the spinal column. Lumbar dorsal horns were dissected and dounce 
homogenized in FACS buffer (0.4% BSA; 15mM HEPES; 2mM EDTA in HBSS) into a cell 
suspension that was centrifuged (430 x g for 30 min at 17°C) over a 37%/70% Percoll 
gradient (Sigma). Microglial cells were isolated from the interface and the total cell number 
determined using a haemocytometer. For each experiment, the lumbar dorsal horns of two 
mice were pooled into one Percoll gradient, constituting one n per sample group (2 x 
saline/naïve and 2 x CAIA).  
 
FACS & qRT-PCR of whole naïve spinal cord: Naïve male and female C57BL6/J mice 
(Harlan, 8 weeks old) were PBS perfused, and microglia were extracted in batches of 4 (n = 2, 
male and female) and stained for flow cytometry as described above. FACS was performed 
using a BD FACS Aria II Cell Sorter at the NIHR BRC flow core facility at King’s College 
London. Live, single CD45/CD11b double positive cells were collected into RLT buffer for 
later batch-controlled RNA extraction with a QIAGEN RNeasy® Micro Kit (74004) as 
described above. The RNA obtained was of high quality ranging from 75 pg/µl to 1490 pg/µl 
(average 451 pg/µl) with RIN values of 8.2-10 (average 9). The material was amplified using 
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the Smart-seq2 protocol [39,40], according to the instructions provided by the authors. qRT-
PCR was conducted using primer pairs listed in Table 1, after having confirmed their 
efficiency and specificity (via melt curve and agarose gel analysis). In a separate experiment, 
additional qRT-PCR was performed on the lumbar part of spinal cords from naïve male and 
female (n=11-13/group) C57BL6/J and Balb/cAnNRj mice (Janvier, 12-18 weeks old). Flash 
frozen tissue was homogenized with bead Tissue Lyser (Qiagen) in Trizol (Thermo Fischer 
Scientific) and mRNA was extracted according to the manufacturer’s protocol. The cDNA 
was prepared by reverse transcription and subjected to qPCR with ABI 7900HT system, using 
TaqMan probes (Applied Biosystems): Iba-1 (Mm00479862_g1), Cd11b (Mm00434455_m1), 
GAPDH (Mm99999915_g1). Threshold cycle values in each sample were used to calculate 
the number of cell equivalents in the test samples using the standard curve method [7]. The 
data was normalized to GAPDH mRNA levels and expressed as relative expression units 
(REU).  
 
FACS of lumbar dorsal horns from CAIA and control mice: Microglial cells were 
centrifuged (230 x g for 3 min at 4°C) and stained with a monoclonal rat anti-Fcrls antibody 
(1:300; clone 4G11, kindly donated by Dr. Oleg Butovsky, Harvard, USA) for 20 min on ice. 
After a wash with FACS buffer and a second spin, cells were incubated for 20 min on ice with 
a goat anti-rat IgG secondary antibody conjugated to APC (1:400; clone Poly4054; 
Biolegend). Cells were washed and spun again, followed by staining with directly conjugated 
rat anti-mouse CD45-PE (1:400; clone 30-F11; Biolegend) and rat anti-mouse CD11b-FITC 
(1:400; clone 3A33; Abcam) antibodies for 20 min on ice. After washing, spinning and 
staining dead cells with Sytox™ blue (1:1500; Life Technologies), cells were sorted with a 
BD Influx™ flow cytometer (core facility at the Center for Molecular Medicine, Karolinska 
Institutet) and purified microglia were collected and lysed in RLT buffer (Qiagen, 79216) 
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containing 1% β-mercaptoethanol. Unstained cells and single staining controls (Sytox™ blue 
stained dead cells and BD Comp beads [BD Biosciences] for FITC, PE and APC 
fluorochromes) were used for compensation. To aid the gating, we used a fluorescence-
minus-one control, where the Fcrls primary antibody was omitted to control for unspecific 
fluorescence of the APC secondary antibody. Naïve and CAIA injected animals in the 
inflammatory phase (day 9 or day 17) were stained for all three markers (Fcrls, CD45, 
CD11b) whereas saline and CAIA injected animals in the post-inflammatory phase (days 55-
65) were only stained for CD45 and CD11b. For data analysis in FlowJo, gates were kept 
constant across conditions in the same experimental set (saline/naïve vs. CAIA). On average, 
3200 microglia were sorted for these experiments in group-matched batches. Only 3 out of 31 
samples contained less than 1000 cells. 
 
RNA extraction: RNA from lumbar dorsal horn sorted microglial cells was extracted using a 
QIAGEN RNeasy® Micro Kit (74004) according to the manufacturer’s instructions with 
minor modifications. If sorted samples contained less than 2,000 cells, then two samples from 
the same condition were pooled into one, constituting one n per sample group (2-4 x saline 
and 2-4 x CAIA mice). RNA quantity and integrity were assessed with a Bioanalyzer using 
Pico Chips (Agilent Technologies).  
 
Sequencing: cDNA library preparation and RNA sequencing were performed by the High 
Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (Oxford 
University). The cDNA libraries were prepared with a SMARTer® Ultra® Low Input RNA 
Kit (Clontech). Samples were amplified and multiplexed on an Illumina HiSeq4000 platform 
to yield 75bp fragments at a depth of at least 27 million reads per sample. Each sample 
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sequenced (n=23) contained lumbar dorsal horn sorted microglia obtained from a pool of 2-4 
saline or CAIA mice. 
 
RNA-Seq Data Analysis: Relevant quality control was performed using the RSeQC algorithm 
[57]. In particular, we checked for gene body coverage, since SMARTer library prep can 
result in significant 3’ bias. Reads were aligned to the mm10 mouse genome using STAR [18] 
(default parameters plus: --outFilterMultimapNmax 1 --clip3pAdapterSeq 
"TGGTATCAACGCAGAGTAC"). Alignment rates were between 83% and 92% (89% on 
average). FPKM values were obtained using the cufflinks algorithm [54] on the Galaxy 
Freiburg server. Genes with an FPKM value of at least 1 in a majority of samples per group 
were considered expressed. For differential gene expression we generated count data with the 
aid of the feature counts algorithm [28] and fed them into the Deseq2 algorithm [30] in R. 
Raw and processed data are available under GEO accession GSE108896. 
 
Statistics: For data besides RNA-seq, differences between two groups were analysed with a 
two-tailed unpaired student’s t-test. Comparisons between more than two groups were 
performed with one-way analysis of variance (ANOVA) for one independent variable or two-
way ANOVA for two independent variables. Multiple comparisons were adjusted with 
Bonferroni post-hoc test. Data is shown as mean ± standard error of the mean (SEM).  
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Results 
CAIA induces transient joint inflammation and persistent mechanical hypersensitivity 
in male and female mice  
Adult male and female mice were subjected to CAIA by an intravenous (i.v.) injection of a 
collagen type-II antibody cocktail on day 0, followed by an intraperitoneal (i.p.) injection of 
LPS on day 5 to boost and synchronize the arthritogenic response. We found significant 
differences in CAIA incidence between males and females; while 90% (27/30) of females 
developed CAIA, only 53.5% (23/43) of males did. Male and female mice that developed 
CAIA presented visually apparent joint swelling and redness from day 6, reaching a peak in 
arthritis score around day 12 and gradually returning to baseline levels around day 30 (Fig. 
1A). While joint inflammation was transient in all mice, mechanical hypersensitivity, which 
was present from day 6, persisted up until the last testing point at day 52 (p<0.05 to p<0.001 
on days 6-52 compared to saline controls) (Fig. 1B). We refer to the period characterized by 
joint swelling and mechanical hypersensitivity as the “inflammatory phase”, and the period 
where joint inflammation has resolved but mechanical hypersensitivity persists as the “post-
inflammatory phase” or “late phase”. Notably, saline matched controls did not present any 
signs of inflammation or mechanical hypersensitivity at any time point. 
 
CAIA does not alter expression levels of spinal CGRP, SP or galanin  
Previously, we have shown that male mice subjected to CAIA do not display spinal changes 
in neuropeptides associated with pain (CGRP, SP and galanin) during the inflammatory and 
post-inflammatory phases of this model. To investigate if female mice show altered 
expression of these neuropeptides after CAIA induction, we compared male and female 
lumbar spinal cords at the peak of the inflammatory phase (15 days) and during the post-
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inflammatory phase (54 days). In line with our previous work, we found no change in 
expression levels for CGRP, SP nor galanin in male mice at the time points examined after 
CAIA induction (Fig. 2). Nevertheless, comparing male and female mice in the late phase, we 
found that galanin expression levels were modestly but statistically higher in male compared 
to female CAIA mice in the late phase (Fig. 2C). However, there was no significant difference 
in spinal galanin levels between control and CAIA mice, independent on sex and time point. 
No changes in CGRP or SP expression were observed in female mice after CAIA induction 
nor in saline controls from both sexes.  
 
CAIA leads to an increase in spinal GFAP and IBA-1 immunoreactivity in male and 
female mice 
We have previously shown that male mice subjected to CAIA display signs of microglial 
activation both in the inflammatory and late phases whereas they only show increased levels 
of GFAP in the post-inflammatory phase of the model [1,6]. To understand whether female 
mice show the same pattern of glial reactivity, we stained lumbar spinal cord sections for the 
astrocytic and microglial activation markers GFAP (Fig. 3A,B) and IBA-1 (Fig. 3C,D), 
respectively. GFAP levels were significantly higher only at day 54 after CAIA induction in 
both males and females as compared to controls. In contrast, we observed significantly higher 
levels of IBA-1 at both 15 and 54 days after CAIA when compared to saline controls 
(p<0.001). IBA-1 can also stain other cell types within the myeloid lineage, particularly 
macrophages. In the context of our study, however, it is still an appropriate choice: in naïve 
conditions, fate-mapping studies have convincingly demonstrated that microglia are the only 
resident myeloid cell in the CNS (see e.g. [47] for review) and, as discussed below, we do not 
observe peripheral immune cell infiltration after CAIA.  
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Intrathecal injection of minocycline or pentoxifylline reverses CAIA-induced 
mechanical hypersensitivity in male but not female mice 
Since both male and female glia displayed signs of reactivity in the CAIA model, we decided 
to investigate whether astrocytes and microglia could be causally involved in the maintenance 
of pain-like behavior. For this purpose, we injected pentoxifylline or minocycline, drugs that 
are frequently used to inhibit spinal astrocytic or microglial actions, respectively, intrathecally 
in males and females during the post-inflammatory phase (day 54-60) of the CAIA model. We 
found that, 6 hours after administration, both pentoxifylline and minocycline significantly 
reversed arthritis-induced withdrawal thresholds to control levels in males, but not females 
(Fig. 4), suggesting that glia play sex-specific roles in arthritis-induced pain. 
 
No differences in whole spinal cord microglial number or microglia-associated gene 
expression are observed between male and female mice 
Since fluorescence-activated cell sorting (FACS) of astrocytes from adult spinal cord is still a 
challenging process, we focused on microglial cells for which there are several established 
sorting protocols [9,17]. To examine if there are sex-associated differences between microglia 
in naive mice, we compared the number of microglia isolated by FACS from the whole spinal 
cord of male and female mice (Fig. 5A) and the levels of Cd11b and Iba-1 mRNA in these 
cells. We found no dimorphic differences in the relative number of CD45+, CD11b+ spinal 
microglial cells, their mean fluorescence intensity or Cd11b or Iba-1 mRNA expression when 
comparing naïve mice of both sexes (Fig. 5B, C; Suppl. Figs. S1 & S2, available at 
http://links.lww.com/PAIN/A666). In order to attest that we could detect sex-associated 
differences we measured the relative levels of the XY linked genes Ddx3y, Eif2s3y and Xist. 
We found significant differences between males and females, as expected (Fig. 5C). We also 
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compared Cd11b and Iba-1 mRNA levels in naïve lumbar spinal cord homogenates from male 
and female mice of different strains. No difference in Cd11b and Iba-1 gene expression 
between C57BL/6 and Balb/c males or C57BL/6 and Balb/c females was observed (Suppl. 
Fig. S4, available at http://links.lww.com/PAIN/A666). 
 
No macrophage infiltration into the lumbar spinal cord is detected during the 
inflammatory phase of CAIA 
Next, we examined if CAIA induction could lead to infiltration of macrophages, as this would 
require separation of resident microglia and infiltrating macrophages in our samples. We 
focused on the lumbar dorsal horn, the region where spinal nociceptive signal processing 
related to the hind limbs takes place. We performed flow cytometry analyses on Percoll-
isolated myeloid cells stained for CD45, CD11b and Fcrls, a protein described to be expressed 
in resident microglia but not on macrophages [35]. The percentage of CD45+, CD11b+ and 
Fcrls+ microglial cells amongst CD45+ immune cells was 99.2% and 99.9% at day 7 and day 
19 of the CAIA inflammatory phase, respectively, similar to the 99.7% of its naïve 
counterpart (Fig. 6). This indicates that macrophage infiltration in the lumbar dorsal horns is 
negligible, if any occurs at all. Based on this finding, we decided to sort microglial cells by 
selecting exclusively single live CD45 and CD11b positively stained cells. 
 
In dorsal lumbar horns, microglial numbers are similar between saline and CAIA 
during the post-inflammatory phase but are lower in females compared to males 
To gain a better insight into any possible differences between the saline and CAIA groups 
during the post-inflammatory phase, we analyzed the flow cytometry data obtained from 
sorted CD45+, CD11b+ microglial cells from lumbar dorsal horns (Fig. 7). The percentage of 
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microglia amongst CD45+ immune cells was mostly above 99% for all conditions (female 
saline: 99.5% ± 0.1; female CAIA: 99.1% ± 0.3; male saline: 99.8% ± 0.08; male CAIA: 
99.8% ± 0.04), corroborating the observations made in naïve and CAIA mice from the 
inflammatory phase (Fig. 6). The proportion of CD45+, CD11b+ microglia, CD45+ immune 
cells and live cells did not significantly differ between saline and CAIA conditions (Fig. 7 and 
Suppl. Fig. S1, available at http://links.lww.com/PAIN/A666).  
 
However, when the data were instead analyzed to study differences between males and 
females, we found a significantly lower percentage of female microglia amongst live cells 
(females: 78.2% ± 2.0; males: 84.7% ± 2.3; p<0.05) and amongst CD45+ immune cells 
(females: 99.3% ± 0.2; males: 99.8% ± 0.06; p<0.05) when compared to males (Fig. 7C). A 
lower proportion of CD45+ immune cells amongst live cells was also observed in females 
(females: 78.7% ± 12.0; males: 84.9% ± 2.3; p<0.05), while the percentage of live cells 
amongst the total number of cells was similar in both sexes (Suppl. Fig. S1, available at 
http://links.lww.com/PAIN/A666).  
 
RNA-sequencing reveals subtle transcriptional differences between male and female 
microglia but not between saline and post-inflammatory CAIA 
In order to investigate transcriptional differences between male and female microglia in the 
context of arthritis-induced pain, we performed RNA-seq on sorted CD45+, CD11b+ microglia 
from lumbar dorsal horns of saline and CAIA mice during the post-inflammatory phase. 
Quality control and alignment scores indicated that the data were of good quality (Suppl. Fig. 
S3, available at http://links.lww.com/PAIN/A666). We mapped an average of 37M unique 
reads back onto the genome (min 27M, max 46.5M). Cufflinks and DESeq2 algorithms were 
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used to generate normalized gene expression values and to decipher differences in gene 
expression between conditions, respectively. We detected a total of 11,567 genes in lumbar 
dorsal horn microglia samples (FPKM >=1 in the majority of replicates in at least one 
condition) and found good overlap of microglial gene expression with previously published 
datasets: 85% of the genes we identified as present or absent were equally present or absent in 
at least 4 other RNA-seq studies performed on purified microglia. 
 
To analyze any possible sex-dependent global variation on the sequenced microglia samples, 
we performed a principal component analysis (PCA). Interestingly, a pronounced separation 
was observed between the male and female microglial samples in the direction of the first 
principal component (25% variance), allowing the categorization of the samples in two well-
defined groups. The overall variance across the first and second principal components was not 
markedly different when comparing saline and CAIA samples (Fig. 8A). 
 
Using the DESeq2 algorithm, we found a total of 21 genes that were differentially expressed 
between male and female microglial cells at an adjusted P value (adj. p) <0.05 (Fig. 8C). Five 
of those (Ddx3y, Eif2s3y, Uty, Xist and Tsix) were X or Y linked genes, which have also 
been described as differentially expressed in human and mouse brain [4,58]. Their presence 
appears to account for most of the variance observed in the PCA, as re-running the analysis 
without Ddx3y, Eif2s3y, Uty, Xist and Tsix resulted in plots that were no longer separated 
into well-defined groups (Fig. 8B).  
 
 
AC
CE
PT
ED
8 8            
In contrast to differences between male and female microglia, differential expression analysis 
between CAIA vs. saline samples did not reveal any convincing differences in gene 
expression between groups. Posthoc power calculations indicate that we are unlikely to have 
missed any large differences: our design gave us an 88% chance to detect a 2-fold change in 
expression in any of our 11,567 microglial genes and a more than 98% chance in the top 
5,700 genes. Only two genes (the pseudo gene Gm11761 and Mesdc1, a gene related to 
mesodermal patterning) passed multiple comparison corrections at adj. p < 0.1. Both of them 
showed extremely low expression, increasing the likelihood of these observations being due 
to statistical noise.  
 
Discussion 
There is an ongoing debate on the involvement of male and female microglia and astrocytes in 
chronic pain conditions. While several groups have reported microglial contribution to pain 
states exclusively in males, other studies suggest that microglia might also play a role in 
females [11,35,48]. It has been proposed that male mice utilize spinal microglia to mediate 
pain while females preferentially use the adaptive immune system, based on observations 
made in models of acute inflammatory and neuropathic pain [48]. However, the detailed 
mechanisms of this process remain controversial [29].  
Equally in the case of astrocytes, both sex-dependent and independent contributions to 
chronic pain have been reported. While pain reversal in spinal nerve injury (SNI) and 
complete Freund’s adjuvant (CFA) models after fluorocitrate and propentofylline treatment 
occurs only in male mice [48], interfering with astrocytic activity using inhibitors for MAPKs, 
Cx43 hemichannel and CXCR2 reduces mechanical hypersensitivity equally in male and 
female mice after chronic constriction injury (CCI) but not in the formalin-injection model of 
inflammatory pain [11].  
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In the context of arthritis-induced pain, direct comparisons between male and female mice 
have so far been outstanding. It has been shown that minocycline can reduce joint nociception 
when injected intrathecally in male mice after antigen-induced arthritis induction (AIA) [42], 
and that intrathecal administration of drugs targeting microglia (P2X7 and cathepsin S 
inhibitors) diminishes the development of mechanical hypersensitivity and attenuates 
microgliosis in female rats in the collagen-induced arthritis (CIA) model [35]. Furthermore, 
we have previously reported that blocking the action of spinal HMGB1, a factor that mediates 
nociceptive effects via TLR4 and induces glia activation, is able to reverse mechanical 
hypersensitivity in the inflammatory and late phases of the CAIA model both in male and 
female mice [1].  
 
In the present study, we wanted to conduct a more thorough investigation of long-lasting 
arthritis-induced pain in both male and female mice. First off, we found some intrinsic 
differences related to the CAIA model. While female mice were more likely to develop joint 
inflammation, mechanical hypersensitivity and spinal glial activation was similar across both 
sexes. In agreement with our previous published data [49], we found no upregulation of 
CGRP, SP or galanin in the lumbar dorsal horns of male mice subjected to CAIA. Similarly, 
we found no changes in CGRP or SP spinal expression levels in female mice after CAIA 
whereas a small but significant difference in galanin was observed between male and female 
mice subjected to CAIA during the post-inflammatory phase. As the levels of galanin were 
slightly higher in male mice, the neuropeptide could in theory have contributed to arthritis-
induced post-inflammatory pain in a sex-specific manner. However, there was no marked 
increase in spinal galanin immunoreactivity over time in male mice. The link is therefore 
weak and potentially false-positive.  
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Interestingly, intrathecal administration of pentoxifylline reversed CAIA-induced mechanical 
hypersensitivity to basal levels in male, but not in female mice during the late phase. These 
findings support the existing evidence for a sex-dependent role of astrocytes in spinal pain 
processing [48] while it contradicts the recent study by Chen et al; which reports a male and 
female contribution of astrocytes in neuropathic pain despite an absent contribution to 
formalin-induced pain [11]. Similarly, we also found dimorphic differences upon minocycline 
treatment. Notably, intrathecal administration of minocycline reversed mechanical thresholds 
to control levels only in male mice during the late phase of the model. While this finding is in 
line with studies using other models of chronic pain, it seems to contradict reports describing 
a possible role of female microglia in the maintenance of arthritis-induced pain. An intriguing 
thought could be that the mechanism of action of minocycline may differ between males and 
females. Thus, while both male and female microglia might be involved in pain maintenance, 
minocycline might only target male microglia in specific contexts. In fact, it is unclear how 
exactly this microglial inhibitor works, but it seems to affect some signalling pathways rather 
than completely inhibiting myeloid activation [19]. Finally, it is worth mentioning that, 
although minocycline is frequently referred to as a selective microglial inhibitor after 
intrathecal delivery, it has effects on peripheral immune cells, neurons and other glial cells 
[34]. Hence, it only seems prudent to interpret our minocycline data with caution, with 
regards to which cell type is ultimately mediating the effect we observed.  
 
In light of this, we took a global approach to ascertain sex-differences between resident male 
and female spinal microglia. Initially, we evaluated gross differences that could be present in 
the whole spinal cord of naïve mice of both sexes. In agreement with recent work [29], we 
found little evidence of sex differences when examining relative numbers of sorted microglia 
or mRNA levels. As a positive control, we tested three XY linked genes (Ddx3y, Eif2s3y, 
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Xist), which did show sexually dimorphic expression, as expected. In contrast to whole naïve 
spinal cord, counts of microglia from lumbar dorsal horns showed a modest, but statistically 
significant difference in numbers between male and female mice. Since experiments were 
carried out in Balb/c vs. C57BL6/J mice, this could be strain specific effects. However, the 
basal levels of Cd11b and Iba1 mRNA did not differ between the two strains. Thus, this sex 
difference might be region specific: male and female microglial numbers have been reported 
to differ in subregions of the brain (hippocampus, amygdala and parietal cortex) [46], and the 
proliferation and activation status of microglia is increasingly thought to be under tight local 
control [44].  
 
Our earlier studies found that the late phase of the CAIA model resulted in spinal changes that 
were reminiscent of those reported in models of neuropathic pain [49]. We had therefore 
predicted that microglia isolated from mice subjected to CAIA would show alterations in their 
transcriptional profile, which might resemble those observed after nerve injury [17,51]. To 
our surprise, no convincing significant transcriptional differences were observed between 
CAIA and saline mice. Importantly, we were well powered to detect changes that were at least 
2-fold in size, while 1.5-fold changes would be much harder to reliably identify for anything 
but the top 3,000 most expressed genes. This may signify that microglial changes in CAIA are 
either subtle and/or localized to a very specific region, such as lamina I and II, making it 
difficult to detect any differences with the strategy employed here. Alternatively, the 
microglial separation protocol used in this study might have impacted the microglial 
transcriptome, obscuring the detection of transcriptomic changes between the saline and 
CAIA conditions. Nevertheless, we believe this to be unlikely, since studies using similar 
isolation techniques still detect differences between conditions [12,16,37,51]. Moreover, a 
study which focused on the impact of isolation techniques on the transcriptome of microglia 
AC
CE
PT
ED
8 8            
suggests that the transcriptome obtained from isolated quiescent or activated microglia closely 
reflects that of homeostatic microglia [36]. Finally, our results could also indicate that 
prominent transcriptomic changes in microglia were transient and short-lasting, as it has been 
recently suggested [17,51]. Hence, microglial activation in CAIA and the possible 
contribution of microglia to arthritis-induced pain could be driven by other factors, such as 
changes in protein expression or epigenetic modifications. Another potential explanation, 
given our present findings, could be that the use of minocycline as a microglial inhibitor is 
misleading and that microglia do not contribute to post-inflammatory pain-like behaviour in 
this model at all. Instead, astrocytes may contribute to spinal sensitization in the CAIA model 
in male mice while direct changes in neuronal factors such as galanin are the main drivers in 
females.  
 
Taken together, these findings suggest that there are only subtle sex-dependent differences in 
microglial expression profiles, and if any, they are independent of treatment (saline, CAIA). 
To what extent these differences could explain the sexually dimorphic reversal of CAIA-
induced pain after minocycline administration remains to be determined. Finally, we did not 
detect any transcriptional correlates to the immunohistochemical signs of increased microglial 
reactivity observed in the late phase of the CAIA model. It is likely that transcriptional 
changes are either subtle and highly localised and therefore difficult to identify with bulk 
isolation techniques or that other factors, such as changes in protein expression or epigenetic 
modifications are at play.  
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Figure legends 
 
Figure 1: CAIA induces transient joint inflammation and persistent mechanical 
hypersensitivity in male and female mice. (A) Joint inflammation was assessed visually by 
counting the number of inflamed digits, paws, wrists and ankles (arthritis score). Male and 
female CAIA groups developed transient joint inflammation while saline injected controls did 
not show any signs of inflammation. (B) Mechanical hypersensitivity was assessed by 
measuring paw withdrawal thresholds using von Frey filaments. Both male and female CAIA 
groups developed persistent mechanical hypersensitivity while the saline injected groups did 
not. Data is presented as mean ± SEM, males n=8; females n=12 mice per group, CAIA vs. 
saline, ***p>0.001, **p>0.01, *p>0.05.  
 
Figure 2: CAIA does not alter the expression levels of CGRP, SP or galanin in the spinal 
dorsal horn. Relative expression based on assessment of fluorescence intensity of (A) CGRP, 
(B) SP and (C) galanin, as well as (D) representative images of immunoreactivity in the 
lumbar spinal cord of male and female mice 15 and 54 days after CAIA induction. Data is 
presented as mean ± SEM, n=8 mice per group, male vs. female CAIA mice on day 54. 
 
Figure 3: CAIA leads to an increase in spinal GFAP and IBA-1 immunoreactivity in 
male and female mice. Relative expression based on assessment of fluorescence intensity of 
(A) GFAP and (C) IBA-1 and (B,D) representative images of immunoreactivity in the lumbar 
spinal cord of male and female mice 15 and 54 days after CAIA induction. Significant 
increase of the astrocyte marker GFAP was observed only in the late phase of CAIA in both 
males and females, while increase in the signal intensity of the microglia marker IBA-1 was 
detected in both CAIA phases in both male and female mice. Data is presented as mean ± 
SEM, n=8 mice per group, CAIA vs. saline, ***p>0.001, **p>0.01. 
 
Figure 4: Intrathecal minocycline and pentoxifylline treatment reverses late-stage 
mechanical hypersensitivity in the CAIA model in male mice only. Bar graphs showing 
the effects of spinal microglia inhibition on withdrawal thresholds of mice. Both minocycline 
and pentoxyfilline reversed mechanical hypersensitivity in males (B,D) but not females (A,C) 
AC
CE
PT
ED
8 8 .            
6 hours after intrathecal administration. Data is presented as mean ± SEM, n=6 per group; 
one-way ANOVA, CAIA+vehicle vs. CAIA+inhibitor, **p>0.01, *p>0.05. 
 
Figure 5: Microglia from whole naïve spinal cord do not show prominent sex differences 
in number or expression level. (A) Gating strategy employed to sort CD11b positive live 
single immune cells. Shown are serial dot plots of the events recorded by the flow cytometer, 
with gates indicating chosen populations that are then displayed in the next adjacent plot. 
Sequentially: Side scatter (SSC) vs Forward scatter (FSC) to distinguish leukocytes from 
debris using their complexity and size; Forward scatter width (FSC-W) vs area (FSC) to 
eliminate leukocyte doublets; FSC vs the live-dead cell marker Sytox blue to eliminate dead 
cells; and finally, FSC versus CD45, a marker for all immune cells. Only the events contained 
in this final CD45+ gate are taken forward for analysis of CD11b positivity. (B) No 
differences could be detected in the number of live microglia obtained from whole spinal cord 
of male and female mice. (C) Myeloid cell markers Iba-1 and CD11b did not show 
differential expression, while XY linked genes Xist, Eif2s3y and Ddx3y were significantly 
more highly expressed in female or male mice, respectively.  
 
Figure 6: Macrophage infiltration into the lumbar dorsal horn is absent or negligible. 
Dot plots of myeloid cells (gated on live CD45+ positive singlets) from naïve and CAIA 
animals isolated during the inflammatory phase (day 7 and day 19). Immune cells were 
stained for CD11b and Fcrls, a microglial cell marker not present in infiltrating macrophages. 
Both naïve and CAIA groups have a similar proportion of CD11b+ /Fcrls+ cells (over 99%) 
indicating that macrophage infiltration during the inflammatory phase of CAIA is negligible. 
The rightmost panel displays a fluorescence minus one (FMO) control, where the Fcrls 
primary antibody was omitted from the staining panel. 
 
Figure 7: Flow cytometry analysis points to fewer dorsal horn microglial cells in females 
than males. Representative gating dot plots of CD45+ CD11b+ microglial cells from saline 
and CAIA (A) female and (B) male mice during the post-inflammatory phase (days 54 to day 
60). (C) Percentage of CD45+ CD11b+ microglia amongst CD45+ immune cells. Females 
show a significant decrease in lumbar dorsal horn microglial and CD45+ cell numbers as 
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compared to males (*p<0.05, one-way ANOVA) whereas the number of live cells does not 
differ (see Suppl. Fig. S1, available at http://links.lww.com/PAIN/A666). No differences were 
found between the saline and CAIA groups. Data is presented as mean ± SEM. 
 
Figure 8. Principal component analysis reveals marked stratification between male and 
female microglia that are mostly due to X-Y linked genetic differences. (A) PCA of male 
and female microglia samples from saline and post-inflammatory CAIA groups. (B) PCA of 
male and female microglia samples in which significantly differentially expressed X and Y 
linked genes have been excluded from the analysis. (C) Volcano plot depicting differentially 
expressed genes between male and female microglia obtained using the Deseq2 algorithm. 
Colored dots represent significantly dysregulated genes at adjusted p<0.05, logFC>1 (dark 
blue for males, dark pink for females) and at adjusted p<0.05, logFC<1 (light blue for males, 
light pink for females). 
 
Table 1: Primers used for qRT-PCR of FACS-purified mouse spinal cord microglia. All 
primers were tested for their efficiency and specificity (via melt curve and agarose gel 
analysis). 
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Dnajb1 (=Hsp40) F TTCGACCGCTATGGAGAGGAA 
 R CACCGAAGAACTCAGCAAACA 
Actn1 F GACCATTATGATTCCCAGCAGAC 
 R CGGAAGTCCTCTTCGATGTTCTC 
Ccnd2 F GAGTGGGAACTGGTAGTGTTG 
 R CGCACAGAGCGATGAAGGT 
Hsp90ab1 F GTCCGCCGTGTGTTCATCAT 
 R GCACTTCTTGACGATGTTCTTGC 
Ddx3y F CCACCAAAGGGGGTTCGT 
 R ACGAGCAAGCATCTGTATCTCC 
Eif2s3y F AGTTAGTGCAGTCAAGGCAGA 
 R CCCCAACCAATTAAACGCCA 
Xist F TTGAACTACTGCTCCTCCGTT 
 R CTCTCTCCAGCACTCTTCACTC 
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